60 Degrees Pharmaceuticals (SXTPW) Competitors $0.05 0.00 (-5.71%) As of 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SXTPW vs. ATNFW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, CLNNW, and COEPWShould you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include 180 Life Sciences (ATNFW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry. 60 Degrees Pharmaceuticals vs. Its Competitors 180 Life Sciences Alpha Tau Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene Coeptis Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership. Does the media favor ATNFW or SXTPW? In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 0 mentions for 180 Life Sciences. 60 Degrees Pharmaceuticals' average media sentiment score of 0.91 beat 180 Life Sciences' score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment 180 Life Sciences Neutral 60 Degrees Pharmaceuticals Positive Is ATNFW or SXTPW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A 60 Degrees Pharmaceuticals N/A N/A N/A Which has preferable earnings and valuation, ATNFW or SXTPW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/A60 Degrees Pharmaceuticals$641.41KN/AN/AN/AN/A Summary60 Degrees Pharmaceuticals beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks. Get 60 Degrees Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTPW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SXTPW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTPW vs. The Competition Export to ExcelMetric60 Degrees PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$237.16M$5.79B$10.15BDividend YieldN/A3.78%5.69%4.61%P/E RatioN/A41.0874.5925.92Price / SalesN/A4,994.05449.5483.33Price / CashN/A13.1937.0859.91Price / BookN/A103.7512.156.29Net IncomeN/A-$90.99M$3.28B$270.85M7 Day PerformanceN/A3.36%0.98%3.36%1 Month PerformanceN/A23.87%7.20%6.41%1 Year PerformanceN/A550.36%63.06%28.26% 60 Degrees Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTPW60 Degrees PharmaceuticalsN/A$0.05-5.7%N/AN/A$0.00$641.41K0.002Gap DownATNFW180 Life SciencesN/A$0.18-1.6%N/A+987.0%$0.00N/A0.007Gap UpDRTSWAlpha Tau MedicalN/A$0.30flatN/A+58.9%$0.00N/A0.0080Gap DownAPLMWApollomicsN/A$0.02-12.4%N/A+72.5%$0.00N/A0.0059Short Interest ↓Gap DownBCTXWBriaCell TherapeuticsN/A$0.03-1.7%N/A-88.2%$0.00N/A0.008Short Interest ↑Gap DownCDIOWCardio DiagnosticsN/A$0.02flatN/AN/A$0.00$19.51K0.007Short Interest ↓Gap DownCELUWCelularityN/A$0.05-9.6%N/A+126.6%$0.00$44.59M0.00220Gap DownCEROWCERo TherapeuticsN/A$0.01-23.0%N/A+36.6%$0.00N/A0.008Gap DownCINGWCingulateN/A$0.06-13.4%N/A-19.6%$0.00N/A0.0020CLNNWCleneN/A$0.03+6.9%N/A-32.6%$0.00$286K0.00100Gap DownHigh Trading VolumeCOEPWCoeptis TherapeuticsN/A$0.02+19.7%N/A+13.1%$0.00$263.56K0.004Gap Up Related Companies and Tools Related Companies ATNFW Alternatives DRTSW Alternatives APLMW Alternatives BCTXW Alternatives CDIOW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives CLNNW Alternatives COEPW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTPW) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
